UY32408A - Macrolido anti-inflamatorio - Google Patents

Macrolido anti-inflamatorio

Info

Publication number
UY32408A
UY32408A UY0001032408A UY32408A UY32408A UY 32408 A UY32408 A UY 32408A UY 0001032408 A UY0001032408 A UY 0001032408A UY 32408 A UY32408 A UY 32408A UY 32408 A UY32408 A UY 32408A
Authority
UY
Uruguay
Prior art keywords
inflammatory
macrolido
compound
diethylaminoenaoyl
homoerythromycin
Prior art date
Application number
UY0001032408A
Other languages
English (en)
Inventor
Caroline Jane Day
Julien Bruno Douilliet
Filic Darko
Leanda Jaen Kindon
Kragol Goran
Zorica Murusic-Istuk
Original Assignee
Glaxo Group Ltd
Glaxosmithkline Istrazivivachi Centar Zagreb D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698466&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY32408(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd, Glaxosmithkline Istrazivivachi Centar Zagreb D O O filed Critical Glaxo Group Ltd
Publication of UY32408A publication Critical patent/UY32408A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

El compuesto 3´-N-desmetil-4¿-O-(2-dietilaminoenaoil)-6-O-metil-9a-aza-9a-homoeritromicina A, que tiene la formula (I): o una sal del mismo, composiciones que comprenden el compuesto, su uso en el tratamiento de enfermedades inflamatorias dominadas por neutrófilos, y métodos para su preparación.
UY0001032408A 2009-01-30 2010-01-28 Macrolido anti-inflamatorio UY32408A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14860909P 2009-01-30 2009-01-30

Publications (1)

Publication Number Publication Date
UY32408A true UY32408A (es) 2010-07-30

Family

ID=41698466

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032408A UY32408A (es) 2009-01-30 2010-01-28 Macrolido anti-inflamatorio

Country Status (23)

Country Link
US (1) US8227428B2 (es)
EP (1) EP2384333B1 (es)
JP (1) JP5437394B2 (es)
KR (1) KR20110099791A (es)
CN (1) CN102378763A (es)
AR (1) AR075340A1 (es)
AU (1) AU2010209732B2 (es)
BR (1) BRPI1006114A2 (es)
CA (1) CA2748847A1 (es)
CL (1) CL2011001829A1 (es)
CO (1) CO6400226A2 (es)
DO (1) DOP2011000242A (es)
EA (1) EA201101139A1 (es)
ES (1) ES2412059T3 (es)
IL (1) IL213871A0 (es)
MA (1) MA32997B1 (es)
MX (1) MX2011008074A (es)
PE (1) PE20120220A1 (es)
SG (1) SG172782A1 (es)
TW (1) TW201038277A (es)
UY (1) UY32408A (es)
WO (1) WO2010086349A1 (es)
ZA (1) ZA201104653B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE476438T1 (de) 2005-01-13 2010-08-15 Glaxosmithkline Zagreb Makrolide mit entzündungshemmender wirkung
KR20110099791A (ko) 2009-01-30 2011-09-08 글락소 그룹 리미티드 항염증 마크롤리드
US20130045939A1 (en) * 2010-03-19 2013-02-21 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
WO2011131749A1 (en) * 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
JP6116206B2 (ja) * 2012-11-26 2017-04-19 クリニプロ株式会社 吸入用パウダーの製造方法
KR20190095372A (ko) * 2017-01-13 2019-08-14 토비시 파마슈티칼 컴패니 리미티드 호중구 활성화 조절제

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US525051A (en) 1894-08-28 Adjustable chair
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
NZ224501A (en) * 1987-05-06 1990-01-29 Adir Tylosin and carbomycin oxime derivatives and pharmaceutical compositions
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
CZ20014120A3 (cs) * 1999-05-18 2003-01-15 Pfizer Products Inc. Nové krystalické formy makrolidového antibiotika
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
RS20050008A (en) 2002-07-08 2007-06-04 Pliva-Istraživački Institut D.O.O., New compounds,compositions and methods for treatment of inflammatory diseases and conditions
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
JP5036557B2 (ja) * 2005-01-13 2012-09-26 グラクソ グループ リミテッド 抗炎症活性デクラジノシル−マクロライド
ATE476438T1 (de) * 2005-01-13 2010-08-15 Glaxosmithkline Zagreb Makrolide mit entzündungshemmender wirkung
JP5065910B2 (ja) * 2005-01-14 2012-11-07 グラクソ グループ リミテッド ビオチンおよび光親和性基を含む、マクロライド標的同定用のマクロライド化合物
KR20110099791A (ko) 2009-01-30 2011-09-08 글락소 그룹 리미티드 항염증 마크롤리드

Also Published As

Publication number Publication date
JP2012516304A (ja) 2012-07-19
JP5437394B2 (ja) 2014-03-12
PE20120220A1 (es) 2012-04-04
US8227428B2 (en) 2012-07-24
IL213871A0 (en) 2011-07-31
MX2011008074A (es) 2011-08-17
ZA201104653B (en) 2012-02-29
TW201038277A (en) 2010-11-01
US20100197623A1 (en) 2010-08-05
MA32997B1 (fr) 2012-01-02
AR075340A1 (es) 2011-03-23
KR20110099791A (ko) 2011-09-08
CA2748847A1 (en) 2010-08-05
CN102378763A (zh) 2012-03-14
CL2011001829A1 (es) 2011-10-14
ES2412059T3 (es) 2013-07-10
CO6400226A2 (es) 2012-03-15
SG172782A1 (en) 2011-08-29
EP2384333B1 (en) 2013-04-17
EP2384333A1 (en) 2011-11-09
EA201101139A1 (ru) 2012-03-30
AU2010209732A1 (en) 2011-07-21
DOP2011000242A (es) 2011-09-15
WO2010086349A1 (en) 2010-08-05
BRPI1006114A2 (pt) 2018-02-06
AU2010209732B2 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
AR077629A1 (es) Mimetico de smac
GT201400111A (es) Triazolopiridinas sustituidas
UY32062A (es) Inhibidores de beta-secretasa
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CL2011002849A1 (es) Composicion anti-inflamatoria que comprende microorganismos sometidos a tratamiento a por lo menos 71,5 grados celsius durante por lo menos 1 segundo; uso de una composicion para tratar o prevenir padecimientos inflamatorios; metodos para proporcionar los microorganismos.
ECSP12011935A (es) Triazolopiridinas
CR20130560A (es) Compuestos de bezotiazol y su uso farmacéutico
CL2011000558A1 (es) Formas cristalinas de un compuesto derivado de 2-tiazolil-4-quinolinil-oxi; sal de sodio del compuesto, composicion farmaceutica que comprende la sal de sodio, util para tratar una infeccion por el virus de la hepatitis c.
GT200500360A (es) Compuestos organicos
CO6280490A2 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
SV2009002865A (es) Uso de oxazolidinonas para el tratamiento y profilaxis de microangiopatias
ECSP13013011A (es) Triazolopiridinas
AR110128A2 (es) Compuesto del grupo de las 3-(imidazoil)-pirazolo[3,4-b]piridinas, composición farmacéutica que lo comprende y método para preparar el mismo
ECSP12012338A (es) Triazolopiridinas sustituidas
DOP2009000287A (es) Oxazolidinonas sustituidas y su uso
AR079050A1 (es) Compuestos benzoimidazolicos y sus usos
CO6400226A2 (es) Micrólido anti-inflamatorio
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
AR090806A1 (es) Glucosidos de pirazol y su utilizacion en el tratamiento de la diabetes tipo i y ii
CR20160016A (es) Pirazolpiridinas sustituidas
BR112015023878A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112015013071A2 (pt) solução de trombina e seus métodos de uso